The Enterprise Value as of December 2025 (TTM) for Summit Therapeutics Inc. (SMMT) is 13.77B

According to Summit Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 13.77B. This represents a change of -4.60% compared to the average of 14.43B of the last 4 quarters.

Summit Therapeutics Inc. (SMMT) Historical Enterprise Value (quarterly & annually)

How has SMMT Enterprise Value performed in the past?

The mean historical Enterprise Value of Summit Therapeutics Inc. over the last ten years is 1.73B. The current 13.77B Enterprise Value has changed 79.55% with respect to the historical average. Over the past ten years (40 quarters), SMMT's Enterprise Value was at its highest in in the June 2025 quarter at 15.51B. The Enterprise Value was at its lowest in in the December 2019 quarter at 4.82M.

Summit Therapeutics Inc. (SMMT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Summit Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Summit Therapeutics Inc. (SMMT) Average Enterprise Value

How has SMMT Enterprise Value performed in the past?

The current Enterprise Value of Summit Therapeutics Inc. (SMMT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Summit Therapeutics Inc. (SMMT) Enterprise Value vs. Peers

How is SMMT’s Enterprise Value compared to its peers?

Summit Therapeutics Inc.’s Enterprise Value is greater than Roivant Sciences Ltd. (13.59B), greater than BridgeBio Pharma, Inc. (13.61B), less than Revolution Medicines, Inc. (15.11B), greater than Ascendis Pharma A/S (11.08B), less than Ionis Pharmaceuticals, Inc. (14.15B), less than Exact Sciences Corporation (20.89B), less than Royalty Pharma plc (24.37B), greater than Moderna, Inc. (9.51B), greater than Avidity Biosciences, Inc. (9.15B), less than Universal Health Services, Inc. (19.87B),

Build a custom stock screener for Summit Therapeutics Inc. (SMMT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Summit Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Summit Therapeutics Inc. (SMMT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Summit Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.